Abstract:Importance: African American individuals have disproportionate rates of coronary heart disease (CHD) but lower levels of coronary artery calcium (CAC), a marker of subclinical CHD, than non-Hispanic White individuals. African American individuals may have distinct metabolite profiles associated with incident CHD risk compared with non-Hispanic White individuals, and examination of these differences could highlight important processes that differ between them. Objectives: To identify novel biomarkers of incident CHD and CAC among African American individuals and to replicate incident CHD findings in a multiethnic cohort. Design, setting, and participants: This analysis targeted plasma metabolomic profiling of 2346 participants in the Jackson Heart Study (JHS), a prospective population-based cohort study that included 5306 African American participants who were examined at baseline (2000-2004) and 2 follow-up visits. Replication of CHD-associated metabolites was sought among 1588 multiethnic participants from the Women's Health Initiative (WHI), a prospective population-based multiethnic cohort study of 161 808 postmenopausal women who were examined at baseline (1991-1995) and ongoing follow-up visits. Regression analyses were performed for each metabolite to examine the associations with incident CHD and CAC scores. Data were collected from the WHI between 1994 and 2009 and from the JHS between 2000 and 2015. All data were analyzed from November 2020 to August 2021. Exposures: Plasma metabolites. Main outcomes and measures: Incident CHD was defined as definite or probable myocardial infarction or definite fatal CHD in both the JHS and WHI cohorts. In the JHS cohort, silent myocardial infarction between examinations (as determined by electrocardiography) and coronary revascularization were included in the incident CHD analysis. Coronary artery calcium was measured using a 16-channel computed tomographic system and reported as an Agatston score. Results: Among 2346 African American individuals in the JHS cohort, the mean (SD) age was 56 (13) years, and 1468 individuals (62.6%) were female. Among 1588 postmenopausal women in the WHI cohort, the mean (SD) age was 67 (7) years; 217 individuals (13.7%) self-identified as African American, 1219 (76.8%) as non-Hispanic White, and 152 (9.6%) as other races or ethnicities. In the fully adjusted model including 1876 individuals, 46 of 303 targeted metabolites were associated with incident CHD (false discovery rate q <0.100). Data for 32 of the 46 metabolites were available in the WHI cohort, and 13 incident CHD-associated metabolites from the JHS cohort were replicated in the WHI cohort. A total of 1439 participants from the JHS cohort with available CAC scores received metabolomic profiling. Nine metabolites were associated with CAC scores. Minimal overlap was found between the results from the incident CHD and CAC analyses, with only 3 metabolites shared between the 2 analyses. Conclusions and relevance: This cohort study identified metabolites that were associated with incident CHD among African American individuals, including 13 incident CHD-associated metabolites that were replicated in a multiethnic population and 9 novel metabolites that included N-acylamides, leucine, and lipid species. These findings may help to elucidate common and distinct metabolic processes that may be associated with CHD among individuals with different self-identified race.

Genetic Determinants Influencing Human Serum Metabolome among African Americans

An Atlas of Genetic Influences on Human Blood Metabolites

Causal effects of human serum metabolites on occurrence and progress indicators of chronic kidney disease: a two-sample Mendelian randomization study

Human Metabolome Associates with Dietary Intake Habits among African Americans in the Atherosclerosis Risk in Communities Study

Genome-wide association study of serum metabolites in the African American Study of Kidney Disease and Hypertension

Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations

Serum Metabolomic Profiling and Incident CKD among African Americans.

Genome‐Wide Association Study of a Heart Failure Related Metabolomic Profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) Study

Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study

Novel genetic associations with serum level metabolites identified by phenotype set enrichment analyses.

Genome-wide association study identifies African-ancestry specific variants for metabolic syndrome

Rare and common genetic determinants of metabolic individuality and their effects on human health

Genotype-based "virtual" metabolomics in a clinical biobank identifies novel metabolite-disease associations

Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases

Identification of genetic variants related to metabolic syndrome by next-generation sequencing

Genetic associations of human metabolic traits

Metabolome-wide association study of estimated glomerular filtration rates in Hispanics

Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study

Abstract MP11: Serum Metabolites Associate with Kidney Function among Bogalusa Heart Study Participants

Genome-wide association and Mendelian randomization analysis prioritizes bioactive metabolites with putative causal effects on common diseases

Metabolomics and Incident Hypertension among Blacks: the Atherosclerosis Risk in Communities Study